The RRP9-JUN axis promotes breast cancer progression via the AKT signalling pathway
In conclusion, this study revealed the crucial role of RRP9 in BC progression and its probable novel mechanism, suggesting that RRP9 may be a promising candidate for the treatment of BC.
Authors
- Yuxin Mu (ORCID: https://orcid.org/0000-0002-8465-6933)
- Jinliang Huan (ORCID: https://orcid.org/0000-0001-6561-5063)
- Xiaojun Liu (ORCID: https://orcid.org/0000-0003-3399-3486)
- Ling Li (ORCID: https://orcid.org/0000-0003-3923-5184)
- Na Wang (ORCID: https://orcid.org/0000-0002-7213-9330)
- Yiqun Du (ORCID: https://orcid.org/0000-0002-2870-6510)
Institutions
- Jiangsu University (CN)
- Shanghai Medical College of Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Affiliated Hospital of Jiangsu University (CN)
- Shanghai Eighth People Hospital (CN)
Publication Details
- Journal
- Biology Direct
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1186/s13062-024-00578-8
- Citations
- 5
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.17